Doctor Aristi Boulmpou
Radboud University Medical Centre, Nijmegen (Netherlands (The))
Membership:
ESC Professional Member
EACVI Member
Biography
Aristi Boulmpou is a Cardiologist currently serving as a clinical CMR fellow at Radboud University Medical Center in Nijmegen. After earning her medical degree from the Aristotle University of Thessaloniki in 2017 and a master of science in healthcare management from the University of Macedonia in 2019, she completed her clinical training in internal medicine and cardiology. Her professional focus is centered on a special interest in cardiovascular imaging. She earned her PhD from the Aristotle University of Thessaloniki in 2025 with research dedicated to the prognosis of paroxysmal atrial fibrillation recurrences. Having completed her advanced echocardiography training at the Third Department of Cardiology of the Aristotle University of Thessaloniki, she is now further specializing in cardiovascular magnetic resonance.
Contributor content
Presentation
Right and left heart functional indices and coupling parameters in the prediction of arrhythmia recurrence among patients with paroxysmal atrial fibrillation
Presentation
How to write a research paper – what the Editor is looking for? (Endorsed by Hellenic Young Cardiologists WG)-Young Panelist (Local Faculty)
Presentation
Serum magnesium and phosphorus values are lower among patients with paroxysmal atrial fibrillation: insights from the PLACEBO study
Presentation
Syncopal patients without prodromes exhibit a diverse pattern of adenosine release during head-up tilt test
Presentation
Prevalence of atrial myopathy among hypertrophic cardiomyopathy patients without atrial fibrillation
Presentation
Impact of antidiabetic treatment with dipeptidyl peptidase-4 inhibitors on the risk of cardiac arrhythmias among patients with type 2 diabetes mellitus
Presentation
Sodium-glucose co-transporter-2 inhibitors and the risk of major arrhythmias: a meta-analysis of the cardiovascular and renal outcome trials
Presentation
Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias
Presentation
Risk of death with sodium-glucose co-transporter-2 inhibitors across the hallmark cardiovascular and renal outcome trials: an updated meta-analysis
Presentation
